IL13RA2 and Familial prostate cancer: By comparing the gene expression of these tumors, we explored biomarkers for predicting the castration resistance of prostate cancer and found that the α2 chain of interleukin‐13 receptor (IL13Rα2) was highly expressed in castration‐resistant models.